Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
This approval represents a significant regulatory milestone, making Prolivâ„¢Rx the first and only at-home neuromodulation ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed by a randomized, double-blinded, sham-controlled trial (30 patients).
For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.
After putting forward preliminary clinical data earlier this year from its neuromodulation implant for reducing chronic migraines, ShiraTronics has raised $66 million in venture capital financing to ...
Spiro Medical, Inc., a Newco established to develop the first of its kind Pulmonary Neuromodulation System (PNM) for the ...
A promising new treatment for some types of tinnitus is called neuromodulation. It involves retraining your brain to ignore the sound of tinnitus through the delivery of sounds, electricity, or other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results